Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081676 | SCV000113607 | benign | not specified | 2013-10-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081676 | SCV000169863 | benign | not specified | 2013-03-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000986821 | SCV000555864 | benign | Mowat-Wilson syndrome | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514375 | SCV000610566 | benign | not provided | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313794 | SCV000848151 | benign | Inborn genetic diseases | 2016-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000986821 | SCV001135957 | likely benign | Mowat-Wilson syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000986821 | SCV002045700 | benign | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000514375 | SCV004151265 | benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | ZEB2: BP4, BS1, BS2 |
Prevention |
RCV004752744 | SCV005354726 | benign | ZEB2-related disorder | 2024-05-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |